Advanced Search

 

Study ID Status Title Patient Level Data
208129/037 Completed Evaluating the consistency of 3 consecutive lots of GSK Biologicals' novel adjuvanted HBV vaccine with single-blind safety evaluation using Engerix™-B as a control, administered according to a 0, 1, 2-month schedule in healthy volunteers (15-50y).
208129/042 Completed To compare the immunogenicity and safety of GSK Biologicals' new adjuvanted hepatitis B vaccine to a double dose of Engerix™-B, in pre-haemodialysis/haemodialysis patients (15 years of age or older)
208129/047 Completed A phase III, clinical trial comparing the persistence of GSK Biologicals new adjuvanted hepatitis B vaccine to a double dose of Engerix™-B at months 24, 30, 36, in pre-haemodialysis/haemodialysis patients (≥15 years of age)
208133/178 Completed A phase III, open-label, multi-centre study to assess the immunogenicity and safety of GlaxoSmithKline Biologicals’ live attenuated varicella vaccine (VarilrixTM), given as a primary vaccination at 4.5 months and 6.5 months post-transplantation, in autologous stem cell/ bone marrow transplant recipients aged 18 years and older. Study Listed on ClinicalStudyDataRequest.com
208136/039 Completed Follow-up to evaluate the the immunogenicity & safety of GSK Biologicals’ MMRV vaccine given as a two-dose schedule in the second year of life, as compared to separate administration of GSK Biologicals’ Priorix® & Varilrix®. Study Listed on ClinicalStudyDataRequest.com
208141/001 Completed An open study in healthy Herpes simplex virus (HSV)-positive adults to evaluate the safety of GSK Biologicals’ candidate gD vaccine, with or without 3D MPL
208141/002 Completed Study in healthy HSV positive and HSV negative adults to evaluate the immunogenicity, reactogenicity and safety of GSK Biologicals' herpes simplex (gD) candidate vaccine with or without 3D-MPL adjuvant administered according to a 0,1, 6 month schedule.
208141/015 Completed Study to compare, in healthy HSV seronegative and HSV seropositive subjects, the humoral and cellular immune response of herpes simplex candidate vaccines containing gD from two different cell lines and using gD-Alum as control
208141/016 Completed Study to evaluate the safety of GSK Biologicals’ Herpes Simplex candidate vaccine (gD2t) with MPL in HSV seropositive or seronegative subjects without genital herpes disease
208141/017 Completed Safety of SmithKline Beecham Biologicals' Herpes Simplex candidate vaccine (gD2t) with MPL & its efficacy to prevent genital herpes disease in HSV positive or negative consorts of subjects with genital herpes disease Study Listed on ClinicalStudyDataRequest.com
208141/039 Completed A Double-Blind, Randomized, Controlled Phase III Study to Assess the Prophylactic Efficacy and Safety of gD-Alum/MPL Vaccine in the Prevention of Genital Herpes Disease in Young Women Who are HSV-1 and -2 Seronegative
208141/040 Completed A study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals' herpes simplex candidate vaccine (gD2‑AS04) in healthy HSV seronegative and seropositive female subjects aged 10-17 years. Study Listed on ClinicalStudyDataRequest.com
208141/042 Completed A Phase III, double-blind, randomized, study to compare: 1) the immunogenicity and safety of 3 commercial scale consistency lots of GlaxoSmithKline (GSK) Biologicals’ herpes simplex candidate vaccine in healthy HSV-1 and -2 seronegative (HSV 1-/2-) female subjects aged 10 – 17 years, and 2) vaccine immunogenicity in healthy HSV 1-/2- females aged 10 – 17 years with healthy HSV 1-/2- adult females Study Listed on ClinicalStudyDataRequest.com
208144/002 Relinquished Multicentric, Surveillance Study to Monitor Safety of GSK Biologicals' Purified Meningococcal Polysaccharide Vaccine of Serogroups ACWY in 3,000 Filipino Subjects Aged above 2 Years When Administered According to the Prescribing Information.
208153 Recruiting A Randomized, 8 Week Clinical Study to Evaluate the Efficacy of an Experimental Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity
208166 Completed A randomized, examiner blind, crossover, in situ erosion study to investigate the efficacy of an experimental dentifrice in remineralization of previously softened enamel compared to a placebo dentifrice
208355/128 Completed Evaluation of safety and efficacy through Post Market Surveillance for Infanrix™, the DTaP mixed vaccine Study Listed on ClinicalStudyDataRequest.com
208397 Completed A Randomized, Open-Label, Clinical Study to Evaluate a Methodology to Assess Food Occlusion Efficacy of a Denture Adhesive in Healthy, Edentulous Subjects
208604 Not yet recruiting Treatment Adherence in Asthma Patients Using Inhaled Corticosteroids (ICS)/Long-Acting Beta Agonists (LABAs)
208651 Active, not recruiting Efficacy analysis of SLE patients treated with Benlysta in studies BEL110751 and BEL110752 investigating BLyS mRNA levels and Type 1 Interferon Inducible Gene Signature Status
208653 Not yet recruiting PGx7689: an exploratory pharmacogenetic efficacy investigation of mepolizumab in subjects with COPD in studies 117106 and 117113
208675 Not yet recruiting A Clinical Method Development Study to Characterise The Efficacy of An Experimental Dual Active Combination Dentifrice For The Relief Of Dentin Hypersensitivity
208683 Not yet recruiting HO-17-18934 - Patient characteristics, treatment pathways and treatment satisfaction amongst SLE patients with renal involvement: Additional analysis of the Adelphi DSP and LPP
208734 Completed A Post-hoc Pooled Analysis of Clinical Data Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dental Hypersensitivity
208793 Completed Meta-Analysis Plan for 207581: Comparing the efficacy of 300 mg single dose tafenoquine with 14-day primaquine 15 mg treatment regimen for the prevention of P. vivax relapse: a non-inferiority analysis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.